跳至主要内容
临床试验/NCT01413698
NCT01413698Unknown不适用

Cough Count Validation

KarmelSonix Ltd.1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2011年9月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
20
试验地点
1
主要终点
Cough count

研究概览

简要总结

People with respiratory infection, asthmatic patients and cystic fibrosis (CF) patients suffer from a multitude of pathologies of airways and are often inflicted with chronic cough.

Treatment of cough in these patients consists of many types of expectorants, cough suppressors, secretion modifiers, inhaled bronchodilators etc. In addition, chest physical therapy (PT) is often prescribed as part of the treatment regime.

The assessment of coughing is currently subjective and based on the symptoms qualitative description as expressed by the patient or parent. Quantitative and objective methods for cough assessment are not available beyond the investigative laboratory and are unique to the specific investigator.

详细描述

Cough is part of the defense mechanism to protect the lung from foreign particles and remove secretions from the airways . While the cough reflex is essential in protecting the lung from foreign materials and infection, its excessive or chronic presence is both bothersome and might interfere with the quality of life, sleep pattern and exercise tolerance of the patient. Such a symptom may potentially be indicative of an on-going pathological process , .

People with respiratory infection, asthmatic patients and CF patients suffer from a multitude of pathologies of airways and are often inflicted with chronic cough.

Treatment of cough in these patients consists of many types of expectorants, cough suppressors, secretion modifiers, inhaled bronchodilators etc. In addition, chest physical therapy (PT) is often prescribed as part of the treatment regime.

The assessment of coughing is currently subjective and based on the symptoms qualitative description as expressed by the patient or parent. Quantitative and objective methods for cough assessment are not available beyond the investigative laboratory and are unique to the specific investigator.

The primary objective of the study is to evaluate the efficacy and validity of novel cough counting device based on the WIM Technology.

研究设计

研究类型
Observational
时间视角
Retrospective

入排标准

年龄范围
2 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age 2-80 years.
  • •Patients with significant chronic cough.
  • •Patients in hemodynamic stability. Patient is not in respiratory distress.
  • •Subject or subject's parents/guardians is able to comprehend and give informed consent for participation in the study.

排除标准

  • •Contraindication to the use of the PulmoTrack™ or performing ARM (Acoustic Respiratory Monitoring).
  • •Hemodynamic instability and/or SOB.
  • •Concurrent additional major illness.
  • •Concurrent participation in any other study.
  • •Physician objection

结局指标

主要结局

Cough count

时间窗: recording lasting up to 24 hours

次要结局

  • WheezeRate (the proportion of wheezing in the respiratory cycle) , respiratory rate, Inspiratory/Expiratory ratio, SPO2, symptom score (according to a questioner)(recording lasting up to 24 hours)

研究者

发起方
KarmelSonix Ltd.
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验

Cough Count Validation | 临床试验